Supreme Court E-Library
Information At Your Fingertips

  View printer friendly version

(NAR) VOL. 19 NO. 2 / APRIL - JUNE 2008

[ DDB BOARD REGULATION NO. 1, S. 2008, May 14, 2008 ]


WHEREAS, pursuant to Section 93, Article XI of Republic Act No. 9165, otherwise known as the Comprehensive Dangerous Drugs Act of 2002, the Dangerous Drugs Board (DDB), after due notice and public hearing, is given the power to reclassify, add to or remove from the list of dangerous drugs any drug or substance;

WHEREAS, under the same section of the said law, the Board, in the exercise of this power, shall take into accord its obligations and commitments to international treaties, conventions and agreements to which the Philippines is a signatory;

WHEREAS, Oripavine which is an opiate and major metabolite of Thebaine and easily convertible to Morphine, has a potential for abuse and is not clinically used due to its severe toxicity effects;

WHEREAS, the United Nations Commission on Narcotic Drugs (CND), through CND Declaration 50/1, has classified Oripavine as a dangerous drug as defined in RA 9165;

WHEREAS, during the public hearing held by the DDB Committee on Public Hearings on May 6, 2008, after due notice, no opposition was raised to the proposed inclusion of Oripavine in the list of dangerous drugs;

WHEREFORE, be it RESOLVED, as it is hereby RESOLVED, to include ORIPAVINE in the list of dangerous drugs and any material, compound, mixture or preparation which contains any quantity of ORIPAVINE, including its salts, isomers, and salts of isomers within the specific chemical designation, by whatever official, common, unusual or bran name or designation, is classified as a dangerous drug which shall be subject to all regulatory and control measures as provided under RA 9165 and the rules and regulations oft Board, provided that this Regulation shall take effect fifteen (15) days after its publication in two (2) newspapers of general circulation and after its registration with the Office of National Administrative Register (ONAR), UP Law Center, Diliman, Quezon City.

Adopted: 14 May 2008

Chairman, Dangerous Drugs Board

Attested by:

(SGD.) Undersecretary EDGAR C. GALVANTE
Secretary of the Board
© Supreme Court E-Library 2019
This website was designed and developed, and is maintained, by the E-Library Technical Staff in collaboration with the Management Information Systems Office.